Key result
Abnormal liver function tests in acute heart failure are associated with increased mortality and rehospitalization.
Why the study?
Despite advances in understanding cardio-hepatic interactions, major gaps remain, including lack of standardised definitions, limited mechanistic studies, and underrepresentation of HFpEF patients.
Liver function test abnormalities in acute heart failure reflect underlying hemodynamic derangements (congestion and hypoperfusion) and serve as important independent prognostic markers for mortality and rehospitalization.
Answers are grounded in this paper and cite their sources.
LFT abnormalities may aid prognostication in acute HF; hypothesis-generating for whether decongestion reverses injury and improves outcomes.
Acute heart failure (AHF) is a systemic condition characterised by multiorgan involvement that varies from subclinical to overt organ failure. The liver is particularly vulnerable due to its dual blood supply and sensitivity to haemodynamic and inflammatory disturbances. Abnormal liver function tests are highly prevalent in patients with AHF, reflecting major mechanisms: passive hepatic venous congestion from elevated central venous pressure, hepatocellular ischaemia from low cardiac output, systemic inflammation and poor metabolic status associated with cachexia. In patients with AHF, liver function tests at admission, during hospitalisation and at discharge are independently associated with rehospitalisation, cardiovascular and all-cause mortality. Persistent abnormalities after hospitalisation often reflect incomplete decongestion or irreversible structural liver changes. Therapeutic strategies focus on decongestion, optimisation of cardiac output and medication adjustments to avoid hepatotoxicity. Despite significant advances in understanding cardio-hepatic interactions, major gaps remain, including the lack of standardised definitions, limited mechanistic studies and the underrepresentation of patients with heart failure with preserved ejection fraction in contemporary research. Future research should explore targeted therapies to improve cardiohepatic interactions and patient outcomes.
No takes yet. Share an insight, caveat, or question.
Geavlete et al. (2026) conducted a review in Acute heart failure. Liver function test abnormalities was evaluated. Liver function test abnormalities are highly prevalent in acute heart failure, reflecting congestion and hypoperfusion, and are independently associated with increased mortality and rehospitalization.
Synapse has enriched 10 related papers. Consider them for comparative context: